These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 8744701)

  • 21. Donor-specific tolerance in fully major histocompatibility major histocompatibility complex-mismatched limb allograft transplants under an anti-alphabeta T-cell receptor monoclonal antibody and cyclosporine A protocol.
    Siemionow MZ; Izycki DM; Zielinski M
    Transplantation; 2003 Dec; 76(12):1662-8. PubMed ID: 14688512
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Induction of stable long-term mixed hematopoietic chimerism following nonmyeloablative conditioning with T cell-depleting antibodies, cyclophosphamide, and thymic irradiation leads to donor-specific in vitro and in vivo tolerance.
    Mapara MY; Pelot M; Zhao G; Swenson K; Pearson D; Sykes M
    Biol Blood Marrow Transplant; 2001; 7(12):646-55. PubMed ID: 11787527
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Specific immunosuppression of corneal allograft rejection by combination of anti-VLA-4 and anti-LFA-1 monoclonal antibodies in mice.
    Hori J; Isobe M; Yamagami S; Mizuochi T; Tsuru T
    Exp Eye Res; 1997 Jul; 65(1):89-98. PubMed ID: 9237869
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential splenic migration of dendritic cells after immunologic unresponsiveness in rat hepatic allografts induced by pretransplant donor-specific transfusion.
    Ohshiro H; Yamaguchi Y; Okabe K; Takai E; Goto M; Zhang JL; Uchino S; Yamada S; Ishihara K; Furuhashi T; Mori K; Ikeda S; Sera Y; Ogawa M
    J Surg Res; 2001 Nov; 101(1):29-36. PubMed ID: 11676551
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Different routes of donor-derived hematopoietic stem cell transplantation for donor-specific chimerism induction across MHC barrier.
    Siemionow MZ; Klimczak A; Unal S
    Transplant Proc; 2005; 37(1):62-4. PubMed ID: 15808547
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Donor hypertension increases graft immunogenicity and intensifies chronic changes in long-surviving renal allografts.
    Pratschke J; Paz D; Wilhelm MJ; Laskowski I; Kofla G; Vergopoulos A; MacKenzie HJ; Tullius SG; Neuhaus P; Hancock WW; Volk HD; Tilney NL
    Transplantation; 2004 Jan; 77(1):43-8. PubMed ID: 14724433
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prolonged survival of rat hepatic allografts pretreated with a single donor-specific blood transfusion: the distribution of donor cells expressing class I major histocompatibility complex antigens in the recipient.
    Yamaguchi Y; Goto M; Makino Y; Kikuchi N; Hamaguchi H; Hisama N; Miyanari N; Mori K; Ogawa M
    J Surg Res; 1996 Feb; 61(1):23-9. PubMed ID: 8769937
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A synthetic CD4-CDR3 peptide analog enhances skin allograft survival across a MHC class II barrier.
    Koch U; Choksi S; Marcucci L; Korngold R
    J Immunol; 1998 Jul; 161(1):421-9. PubMed ID: 9647252
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Graft-facilitating doses of ex vivo activated gammadelta T cells do not cause lethal murine graft-vs.-host disease.
    Drobyski WR; Majewski D; Hanson G
    Biol Blood Marrow Transplant; 1999; 5(4):222-30. PubMed ID: 10465102
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Induction of tolerance after facilitation of engraftment with a monoclonal antibody anti-MHC class II in MHC fully allogeneic transplantation.
    Hamelmann E; Wottge HU; Gassmann W; Uharek L; Müller-Ruchholtz W
    Transplant Proc; 1990 Oct; 22(5):2340-1. PubMed ID: 2219397
    [No Abstract]   [Full Text] [Related]  

  • 32. Tissue distribution of MHC class II--positive cells, their down-manipulation by monoclonal antibodies and potential role in organ allograft immunogenicity.
    Krzymański M; Müller-Ruchholtz W
    Arch Immunol Ther Exp (Warsz); 1992; 40(3-4):177-81. PubMed ID: 1300981
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The origin of Ia antigen-expressing cells in the rat kidney.
    Gurner AC; Smith J; Cattell V
    Am J Pathol; 1987 May; 127(2):342-8. PubMed ID: 2437803
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vivo induction of Ia antigen in resident leukocytes in the normal rat renal glomerulus.
    Gurner A; Smith J; Cattell V
    Lab Invest; 1986 Nov; 55(5):546-50. PubMed ID: 3534447
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Depletion of donor class II MHC positive passenger cells and reduction of immunogenicity in longstanding rat heart allografts.
    Klempnauer J; Steiniger B
    Transplant Proc; 1989 Feb; 21(1 Pt 1):487. PubMed ID: 2650182
    [No Abstract]   [Full Text] [Related]  

  • 36. Transplantation-induced immune complex kidney disease in rats with unilateral manifestation in the allografted kidney.
    Thoenes GH; Pielsticker K; Schubert G
    Lab Invest; 1979 Oct; 41(4):321-33. PubMed ID: 158673
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gamma interferon treatment in vivo provokes accumulation of activated monocytes in the venous circulation of rats.
    Steiniger B; Schröder D; Lück R; Luciano L; van der Meide PH
    Am J Pathol; 1990 Apr; 136(4):967-78. PubMed ID: 2109537
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Class II antigens and interleukin 2 expression in renal allograft recipients.
    Glapinski T; Lao M; Wasik M; Lagodzinski Z; Nowaczyk M; Gorski A
    Transplant Proc; 1989 Feb; 21(1 Pt 1):319. PubMed ID: 2650133
    [No Abstract]   [Full Text] [Related]  

  • 39. Expression of MHC class I and class II antigens in cultured human kidney cells.
    Worlock AJ; Brown S; Horsburgh T; Bell PR
    Transplant Proc; 1989 Feb; 21(1 Pt 1):322. PubMed ID: 2650135
    [No Abstract]   [Full Text] [Related]  

  • 40. Different distributions of T cell subsets between perivascular and interstitial peritubular areas during rejection of rat renal allografts: a quantitative and ultrastructural study using monoclonal antibodies.
    Ishikura H; Matsuura A; Ishii Y; Natori T; Kikuchi K; Aizawa M
    Clin Exp Immunol; 1985 Dec; 62(3):570-8. PubMed ID: 3910319
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.